5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isophthalic acid, 95.0%, 5g

5-fluoro-1-methyl-1H-indole-2-carbaldehyde, 95.0%, 1g

N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine, 95.0%, 5g

4-Bromo-3-chloro-benzoic acid ethyl ester, 95.0%, 1g

2-(2-Fluoro-5-methoxypyridin-3-yl)acetic acid, 97.0%, 1g

N-(tert-Butyl)-2-(methylamino)acetamide hydrochloride, 98%, 5g

AMINO-PEG6-ALCOHOL, 95.0%, 1g

Methyl 4-hydroxypiperidine-2-carboxylate hydrochloride, 97%, 100mg

1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one, 95.0%, 250mg

Fmoc-9-aminononanoic acid, 98.0%, 100mg

GC capillary column ROTI®Cap-FFAP, 25 m, 0.32 mm, 0.50 µm, 1 Piece(s)

4,5-Difluoro-2-methoxybenzoyl chloride, 5g

(Boc-Cys-OH)2, 98.0%, 5g